fda tirzepatide compounding warning 2024 2025 giant Empower Pharmacy cuts hundreds of staff, stops New Jersey operations FDA Shares Safety Data About

(NCBI) Side Effect Profile Commonly reported class effects include: GI effects (nausea, vomiting, diarrhea/constipation) Risk signals/monitoring considerations discussed in prescribing information and safety guidance (e.g., pancreatitis warnings, gallbladder disease considerations) Weight loss including fat (NCBI) and muscle

Because the goal isn't just to lose weight while taking a GLP-1 medication

Semaglutide once faced a global shortage

Metformin is generally the recommended first-line oral anti-hyperglycaemic agent for type 2 diabetes therapy

Here, we examined the effects of ARTHS mutations on histone acetylation in human cells and the effects of heterozygous loss of Kat6a in mice ( Kat6a +/ ) on learning, memory, activity, and sociability